20911 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
MULTILAMELLAR LIPID VESICLE COMPOSITIONS AND METHODS OF USE
#302Autologous HIV-1 proteins for the treatment of latent HIV-1 infection
#303Pharmaceutical composition for suppressing cell transplant rejection
#304Inhibitors of fusion between viral and cell membranes as well as compositions and methods of using them
#305Antimicrobial compositions and method of use thereof
#306METHOD FOR REDUCING AND/OR DELAYING PATHOLOGICAL EFFECTS OF HUMAN IMMUNODEFICIENCY VIRUS I (HIV) OR FOR REDUCING THE RISK OF DEVELOPING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
#307Pharmaceutical compositions for prevention or treatment of neurodegenerative diseases
#308Acinetobacter lysins
#309Cell-permeable peptide system for treating diseases caused by glutamate excitotoxicity
#310Chloride salt of TAT-NR2B9c
#311Bacteriophage gene 3 protein compositions and use as amyloid binding agents
#312Formulations of hepalatide
#313Decorin gene delivery system and cancer treatment
#314JNK inhibitor molecules for treatment of various diseases
#315Use of a HIV derived accessory protein for the reactivation of latent HIV
#316Lyophilized formulation comprising tat-NR2B9C, histidine and trehalose
#317MPER-liposome conjugates and uses thereof
#318Methods and materials for reducing the severity of viral infections
#319Therapeutic applications of Smad7
#320Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4
#321PTD-SMAD7 THERAPEUTICS
#322Use of AAV-expressed M013 protein as an anti-inflammatory therapeutic
#323Derivative peptide compounds and methods of use
#324Aluminum compounds for use in therapeutics and vaccines
#325Engineered polypeptide agents for targeted broad spectrum influenza neutralization
#326Peptide compounds to regulate the complement system
#327ADAM10 INHIBITION TO TREAT FRAGILE X SYNDROME
#328Methods of treating obesity by administering a TAT peptide
#329Protein scaffolds and methods of use
#330DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS
#331Compositions and methods comprising hydrocarbon-stapled polypeptides
#332Vaccines with interleukin-33 as an adjuvant
#333POLYAMIDE BASED PEPTIDODENDRIMER CONJUGATES
#334Therapy for subarachnoid hemorrhage and ischemia
#335Autologous HIV-1 proteins for the treatment of latent HIV-1 infection
#336CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#337Peptides having specificity for the lungs
#338IMMUNOSUPPRESSIVE COMPONENTS ASSOCIATED WITH RETROVIRAL REPLICATING VECTORS
#339Use of immune suppressive domains as medicaments
#340Air cannon and associated launch canister for a line-fouling system
#341Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins
#342Combination treatment for atopic dermatitis
#343Composition and uses thereof
#344Aluminum compounds for use in therapeutics and vaccines
#345LENTIVIRAL VECTORS WITH TROPISM TO MOTOR NEURONS COMPRISING AN ANTIBODY THAT BINDS TO A PRE-SYNAPTIC TERMINAL RECEPTOR ON THE NEUROMUSCULAR JUNCTION AND A FUSOGENIC PROTEIN
#346Methods for producing peptides including HERV-W envelope motifs and for producing antibodies specific for the peptides
#347Therapeutic compositions for neutralizing type I interferons, and methods of use
#348Fusion proteins and immunoconjugates and uses thereof which are specific for glycophorin A
#349Expression of HIV inhibitors by Mesenchymal stem cells
#350Suppression of cancer metastasis
#351Simian Subfamily B Adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and Uses Thereof
#352PTD-SMAD7 therapeutics
#353HIV-1 integrase derived peptides and compositions
#354Lipopeptides for use in treating liver diseases and cardiovascular diseases
#355Bacteriophage gene 3 protein compositions and use as amyloid binding agents
#356Bacteriophage gene 3 protein compositions and use as amyloid binding agents
#357METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES
#358Compositions and methods involving endogenous retrovirus proteins
#359Antiviral rift valley fever virus peptides and methods of use
#360Method for cellular RNA expression
#361Polypeptide vaccine
#362Stabilized trimeric HIV-1 GP41 fusion inhibitor polypeptides comprising the N-terminal heptad repeat (NHR) and foldon (FD) trimerization motif
#363Pharmaceutical composition
#364Therapeutic applications of SMAD7
#365bacteriophage lysins for detection and treatment of gram positive bacteria
#366Method for in-vitro preparation of double-layered virus-like particles of rotavirus
#367Compositions and methods for measles virus inhibition
#368Cell penetrating peptides
#369Composition capable of improving stability of bacteriophage lysin proteins
#370Methods and peptides for preventing and treating a BCR-ABL and a C-ABL associated disease
#371Model systems and treatment regimes for treatment of neurological disease
#372METHODS AND COMPOSITIONS FOR TREATING AMYLOID DEPOSITS
#373Replication competent pseudo-type retrovirus vector system
#374PEPTIDES DERIVED FROM HIV GP41 FOR TREATING T-CELL MEDIATED PATHOLOGIES
#375Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein
#376Methods for inducing migration by dendritic cells and an immune response
#377Peptide compounds to regulate the complement system
#378Polypeptide mixes with antibacterial activity
#379Compositions for promoting HIV-1 virolysis and methods using same
#380Methods of producing and using regulatory B-cells
#381COMPOSITIONS AND METHODS FOR TREATING PTSD AND RELATED DISEASES
#382Infectious bursal disease (IBDV) vaccine compositions
#383Treatment of cancers with immunostimulatory HIV tat derivative polypeptides
#384Viral vectors and their use in therapeutic methods
#385GB virus C (hepatitis G virus) E2 glycoprotein as an immunomodulatory agent
#386Viral fusion protein treatment for CCR8 mediated diseases
#387Materials and methods for treatment of cystic fibrosis and for induction of ion secretion
#388Enhanced glycemic control using Ad36E4orf1 and AKT1 inhibitor
#389Methods of stimulating protective immunity employing Dengue viral antigens
#390Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#391Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes
#392Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
#393Compositions and methods for treating influenza
#394Malaria vaccine
#395Method for preventing and treating Typhimurium infection
#396Polyoma virus JC peptides and proteins in vaccination and diagnostic applications
#397Neuron generation, regeneration and protection
#398Bacteriophage gene 3 protein compositions and use as amyloid binding agents
#399Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions
#400Multivalent liposome formulations
#401ESTROGEN-RECEPTOR BASED LIGAND SYSTEM FOR REGULATING PROTEIN STABILITY
#402Oncolytic viruses and methods for treating neoplastic disorders
#403Inhibition of innate immune response
#404Methods and materials for reducing the severity of viral infections
#405Compositions comprising a Brd4 antagonist and methods for the treatment of HIV
#406METHOD OF INHIBITING PAPILLOMAVIRUS PROLIFERATION AND TREATING PAPILLOMAVIRUS INFECTION
#407PEPTIDE DERIVATIVE FUSION INHIBITORS OF HIV INFECTION
#408Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
#409Immunosuppressive Tat derivative polypeptides
#410Modified viral structural protein with antiviral activity
#411COMPOSITIONS AND METHODS FOR EXOSOME TARGETED EXPRESSION
#412Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
#413Immune suppressor and its use
#414bacteriophage lysins for detection and treatment of gram positive bacteria
#415Compositions and methods for coronavirus inhibition
#416Methods of stimulating protective immunity employing Dengue viral antigens
#417Human antibodies and antibody-drug conjugates against CD74
#418COMPOSITIONS AND METHODS FOR EXOSOME TARGETED EXPRESSION
#419Conformationally Specific Viral Immunogens
#420Compositions and methods for treating glioblastoma GBM
#421Mucosal adjuvant composition
#422Method for producing bio-active agent for the prevention of disease caused by White Spot Syndrome Baculovirus Complex and a bio-active agent derived thereof
#423Aluminum compounds for use in therapeutics and vaccines
#424Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
#425Composition comprising VLP and amyloid beta peptide
#426Peptide compounds to regulate the complement system
#427Compositions and methods for inducing migration by dendritic cells and an immune response
#428Compositions and methods useful in enhancement of memory
#429Methods and compositions for controlling assembly of viral proteins
#430Method of purifying HIV/SIV Nef from exosomal fusion proteins
#431Anti-tumor fibrillar human serum albumin methods and compositions
#432Benzonapthyridine compositions and uses thereof
#433Microvesicles derived from cell protoplast and use thereof
#434Modulation of UL24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection
#435LATENT HUMAN IMMUNODEFICIENCY VIRUS REACTIVIATION
#436Antimicrobial compositions and methods of use thereof
#437Papillomavirus virus-like particle or capsomere formulation and its use as microbicide
#438Viral Complement Control Proteins for Eye Disorders
#439Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy
#440COMPOSITIONS AND METHODS FOR TREATMENT OF PARKINSON'S DISEASE
#441Suppressors of RNA Silencing as Modulators of miRNA Levels
#442Adenovirus E1A fragments for use in anti-cancer therapies
#443Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#444Codon-optimized polynucleotide-based vaccines against human infection
#445Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment of Alopecia
#446Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Dermatology Related Genetic Diseases
#447Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For the Treatment of Psoriasis
#448Therapeutics to inhibit MLL-menin interaction for treating leukemia
#449Fibrillar albumin for use in inhibiting cancer growth
#450Glioprotectant peptide for use in the treatment of amyotrophic lateral sclerosis (ALS) and methods related thereto
#451SUPPRESSION OF CANCER METASTASIS
#452Treatment of influenza virus infection
#453METHODS AND COMPOSITIONS FOR REGULATION OF NEUROLOGICAL CONDITIONS
#454Model systems and treatment regimes for treatment of neurological disease
#455Peptides for the treatment of hearing
#456PLASMID FOR EXPRESSION OF TRANSGENES IN PLANTS
#457Allosteric Modulation of the Dopamine Transporter Protein for the Treatment of HIV-1 Induced Neurologic Dysfunction
#458Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer
#459DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS
#460METHODS FOR TREATING SEPTIC SHOCK
#461EXPRESSION OF VIRUS ENTRY INHIBITORS AND RECOMBINANT AAV THEREFOR
#462Production of nucleic acid
#463TAT Protein for preventing or treating AIDS
#464Oncolytic viruses and methods for treating neoplastic disorders
#465Neuron generation, regeneration and protection
#466METHODS FOR CREATING OR IDENTIFYING COMPOUNDS THAT BIND TUMOR NECROSIS FACTOR ALPHA
#467Tat-Based Tolerogen Compositions and Methods for Making and Using Same
#468Agents for treatment of HCV and methods of use
#469Methods and compositions for inhibiting viral entry into cells
#470ADJUVANT COMBINATIONS COMPRISING A MICROBIAL TLR AGONIST, A CD40 OR 4-1BB AGONIST, AND OPTIONALLY AN ANTIGEN AND THE USE THEREOF FOR INDUCING A SYNERGISTIC ENHANCEMENT IN CELLULAR IMMUNITY
#471Adenovirus Ad36 E4 orf1 protein for prevention and treatment of non-alcoholic fatty liver disease
#472Process for the production of biologically active HIV-1 tat protein
#473Compositions and methods for the treatment of viral infections
#474Methods of treating ocular and other diseases with Syn-134R polypeptide
#475Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity
#476Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
#477USE OF THE FOAMY VIRUS BET PROTEIN FOR INACTIVATING APOBEC
#478Viral Sequences and Uses Thereof
#479Enhanced immune response against infections
#480T-cell immunogens derived from anti-viral proteins and methods of using same
#481DENDRITIC CELL IMMUNORECEPTORS (DCIR)-MEDIATED CROSSPRIMING OF HUMAN CD8+ T CELLS
#482Bifunctional molecules for inactivating HIV and blocking HIV entry
#483INCLUSION BODIES, BACTERIAL CELLS AND COMPOSITIONS CONTAINING THEM AND USES THEREOF
#484HIV-1 integrase derived stimulatory peptides interfering with integrase—Rev protein binding
#485FUSION PROTEINS OF APOPTIN-PROTEIN TRANSDUCTION DOMAIN OF CARBOXYL-TERMINUS OF EC-SOD
#486Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy
#487Highly Potent Peptides To Control Cancer And Neurodegenerative Diseases
#488Modified Tat Oyi protein with enhanced immunogenicity
#489METHOD FOR INDUCING CYTOTOXIC T-CELLS, CYTOTOXIC T-CELL INDUCER, AND PHARMACEUTICAL COMPOSITION AND VACCINE EMPLOYING SAME
#490Engineered synergistic oncolytic viral symbiosis
#491Engineered polypeptide agents for targeted broad spectrum influenza neutralization
#492Methods of inhibiting retrovirus replication and infectivity
#493METHODS OF INDUCING PLURIPOTENCY INVOLVING SOX2 PROTEIN
#494MODULATION AND REPLETION/ENHANCEMENT OF THE COMPLEMENT SYSTEM FOR TREATMENT OF TRAUMA
#495Compositions and methods for therapeutic delivery with microorganisms
#496Treatment of mood and anxiety disorders
#497Compositions and methods for therapeutic delivery with microorganisms
#498Compositions and methods for therapeutic delivery with microorganisms
#499Compositions and methods for therapeutic delivery with microorganisms
#500Compositions and methods for therapeutic delivery with microorganisms
#501Compositions and methods for therapeutic delivery with microorganisms
#502Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
#503ANTI-ANGIOGENIC COMPOSITIONS AND THERAPEUTIC APPLICATIONS THEREOF
#504Flavivirus fusion inhibitors
#505Anti-tumor fibrillar human serum albumin methods and compositions
#506Molecules, compositions, methods and kits for applications associated with flaviviruses
#507Modulation of Adenoviral Tropism
#508Compositions and Methods to Inhibit HPV Infection
#509Composition comprising VLP and amyloid beta peptide
#510HCV NS3-NS4 Protease Resistance Mutants
#511Immunizing compositions comprising HIV-1 proviral constructs with an inactive p6 gag TSG101 UEV binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface
#512Viral vectors and their use in therapeutic methods
#513Production of nucleic acid
#514Artificially synthesized peptide
#515METHODS FOR TREATING SEPTIC SHOCK
#516Oncolytic virus replicating selectively in tumor cells
#517FUSION PEPTIDE THERAPEUTIC COMPOSITIONS
#518REAGENTS FOR INDUCING AN IMMUNE RESPONSE
#519Interferon antagonists, antibodies thereto and associated methods of use
#520Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver
#521Stabilizing alkylglycoside compositions and methods thereof
#522Method of inhibiting HIV-1 replication by administering modified GP41 C34 peptide derivatives with enhanced pharmacological properties
#523DIAGNOSING AND PROTECTING HORSES AGAINST PAPILLOMAVIRUS
#524Melanoma-Associated Endogenous Retrovirus (MERV) Derived Peptide Sequences And Their Therapeutic/Diagnostic Use
#525Modifications of apoptin
#526Method of Cancer Treatment with Antagonists of FAS Inhibitors
#527Modulation of platelet aggregation
#528Compositions and Methods for the Inhibition of Hepatitis C Viral Replication with Structural Analogs
#529Use of Measles Virus Nucleoprotein for Treating Atherosclerosis
#530Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof
#531Method and medicament for inhibiting the infection of influenza virus
#532Influenza A virus vaccines and inhibitors
#533METHODS AND COMPOSITIONS FOR REGULATION OF NEUROLOGICAL CONDITIONS
#534Stabilizing alkylglycoside compositions and methods thereof
#535Stabilized trimeric HIV-1 gp41 fusion polypeptides comprising the N-terminal heptad repeat (NHR) and foldon (FD) trimerization motif
#536Persistently infective vector
#537Five-helix protein
#538Therapeutic peptides and vaccines
#539Composition and methods for the inhibition of membrane fusion by paramyxoviruses
#540Methods and compositions for inhibition of viral replication
#541Antimicrobial protein specific to
#542TREATMENT OF HIV AND AIDS USING PROBIOTIC LACTOBACILLUS REUTERI
#543Allosteric Modulation of the Dopamine Transporter Protein for the Treatment of HIV-1 Induced Neurologic Dysfunction
#544Methods for Treatment of HIV and Other Infections Using A T Cell or Viral Activator and Anti-Retroviral Combination Therapy
#545ISOLATED DNA FRAGMENT OF THE HUMAN A33 PROMOTER AND ITS USE TO CONTROL THE EXPRESSION OF A HETEROLOGOUS GENE IN TUMOR CELLS
#546METHOD AND COMPOSITION FOR TREATMENT OF NEOPLASMS
#547Peptides for the regulation of neurotransmitter sequestration and release
#548Method of inhibiting HIV replication utilizing the P7 nucleocapsid protein
#549Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4
#550GLUT-1 as a receptor for HTLV envelopes and its uses
#551Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors
#552Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis
#553Peptide and treatment for HIV-1 infection
#554Use of Antiviral Peptides For Treatment of Infections Caused by Drug-Resistant HIV
#555COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#556CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#557THERAPEUTIC, PROPHYLACTIC AND DIAGNOSTIC AGENTS FOR HEPATITIS B
#558STABILIZING ALKYLGLYCOSIDE COMPOSITIONS AND METHODS THEREOF
#559Method of Enhancing Remyelination in Demyelinating Diseases of the Central Nervous System
#560Stabilizing alkylglycoside compositions and methods thereof
#561Therapeutics to inhibit MLL-menin interaction for treating leukemia
#562Inhibition of membrane fusion proteins
#563Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
#564HIV-I GP41 FUSION PEPTIDES FOR IMMUNOMODULALTION
#565Influenza virus inhibiting peptides
#566NEUROPROTECTIVE INTEGRIN-BINDING PEPTIDE AND ANGIOPOIETIN-1 TREATMENTS
#567Method for Discovering Inhibitors of the Epstein-Barr Virus-Induced Gene 3 (EBI3) and Derivatives Thereof for the Treatment of Metastasizing Tumors and Allergic Asthma
#568Flavivirus fusion inhibitors
#569CELL-SURFACE DECORATION WITH ACTIVE AGENTS
#570TAT-BASED TOLEROGEN COMPOSITIONS AND METHODS FOR MAKING AND USING SAME
#571Use Of The Foamy Virus Bet Protein For Inactivating APOBEC
#572Stabilizing alkylglycoside compositions and methods thereof
#573HCV NS3-NS4 protease resistance mutants
#574Methods and compositions for inhibition of viral replication
#575Expression of virus entry inhibitors and recombinant AAV therefor
#576Methods and compositions for treating brain diseases
#577GENE TRANSFER INTO AIRWAY EPITHELIAL STEM CELL BY USING LENTIVIRAL VECTOR PSEUDOTYPED WITH RNA VIRUS OR DNA VIRUS SPIKE PROTEIN
#578Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
#579Peptide Domain Required For Interaction Between The Envelope of a Virus Pertaining to The Herv-W Interference Group and an Hasct Receptor
#580Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/diagnostic use
#581Multivalent HIV immunogenic compositions comprising a pool of lipidated and nonlipidated peptides representing Gag and Env variable regions
#582IMMUNOMODULATORY COMPOSITIONS AND USES THEREFOR
#583BACTERIOPHAGE AND PROPHAGE PROTEINS IN CANCER GENE THERAPY
#584Amphipathic alpha-helical peptide compositions as antiviral agents
#585COMPOSITIONS AND METHODS OF USING CAPSID PROTEIN FROM FLAVIVIRUSES AND PESTIVIRUSES
#586Virus derived antimicrobial peptides
#587MOLECULES, COMPOSITIONS, METHODS AND KITS FOR APPLICATIONS ASSOCIATED WITH FLAVIVIRUSES
#588Use of Antagonists of Cxcl13 or Cxcr5 for Treating Wounds of Fibrotic Diseases
#589Methods for activating peripheral blood mononuclear cells (PBMCs) by administering human immunodeficiency virus (HIV) Tat under physiological oxygen levels
#590Novel formulations for delivery of antiviral peptide therapeutics
#591Methods of treating dementia by administering virus-like particles coupled to Aβ
#592Novel Therapeutic Use of Viral Inflammation Modulatory Protein in Blocking Xenograft Rejection
#593Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
#594HIGH MOLECULAR WEIGHT MEDICINE-CONTAINING PREPARATION IN POWDER FORM FOR ADMINISTRATION THROUGH MUCOSA
#595DIAGNOSING AND PROTECTING HORSES AGAINST PAPILLOMAVIRUS
#596Process to produce fibrillar proteins
#597Glut-1 as a receptor for HTLV envelopes and its uses
#598Stabilizing alkylglycoside compositions and methods thereof
#599Inhibitors of hepatitis C virus
#600ADJUVANT COMBINATIONS COMPRISING A MICROBIAL TLR AGONIST, A CD40 OR 4-1BB AGONIST, AND OPTIONALLY AN ANTIGEN AND THE USE THEREOF FOR INDUCING A SYNERGISTIC ENHANCEMENT IN CELLULAR IMMUNITY